Advertisement

Topics

Vivace raises $25mm in Series B round

15:40 EDT 30 Jun 2017 | Elsevier Business Intelligence

Vivace Therapeutics Inc. (oncology drug discovery) raised $25mm in its Series B round from new investors Cenova (lead) and Se...

Original Article: Vivace raises $25mm in Series B round

NEXT ARTICLE

More From BioPortfolio on "Vivace raises $25mm in Series B round"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...